Chris Benko is the CEO and co-founder of Koneksa Health, a health information technology company that is improving measurement of clinical endpoints using digital tools and remotely collected patient data. Koneksa works with the pharmaceutical industry to create and support clinical trial measures that improve signal detection, are more patient-centric and more accurately reflect real-world behavior than traditional studies. Prior to founding Koneksa, Chris was a vice president in Merck’s corporate strategy office working with its Global Health Innovation venture capital fund. He began his career at Merck in 1995 and progressed through roles in information technology, as well as talent and organizational development, working in R&D, commercial, and at the corporate level as vice president for global talent management.